Highlights

  • IHI seeks exposure to US manufacturers and distributors of medical devices and equipment.
  • The fund reports NAV of USD 56.47 as of 2 November 2026.
  • IHI lists an expense ratio of 0.37% and distributes quarterly.

iShares U.S. Medical Devices ETF (NYSE Arca:IHI) seeks to track US manufacturers and distributors of medical devices and equipment. Its NAV stood at USD 56.47 as of 2 November 2026. Net Assets totalled USD 3,741,314,361 as of 2 November 2026.

Medical Devices Within a Dedicated Industry Index

IHI tracks the Dow Jones U.S. Select Medical Equipment Index. The benchmark focuses on the medical devices segment of the US Equity market. It can include companies of different sizes within that defined industry universe.

The fund uses representative sampling, selecting investments intended to resemble the benchmark’s overall characteristics. It may therefore hold a different collection of securities from the index while seeking a similar Investment profile.

Portfolio Composition and Exposure

IHI reported 49 holdings as of 30 October 2026. Its allocation by Market Value included Health Care Equipment at 99.81% and Cash and/or Derivatives at 0.19% as of 30 October 2026.

The fact sheet dated 30 September 2026 identified holdings including Abbott Laboratories at 17.77%, Intuitive Surgical at 14.92% and Medtronic plc at 11.47%. These position weights refer to that reporting date and can change as the portfolio and market values evolve.

The same fact sheet reported a P/E ratio of 29.56x and a P/B ratio of 3.53x. These valuation measures complement the holdings information with Earnings and book-value characteristics associated with the equity portfolio.

Fees and Distribution Policy

The published expense ratio is 0.37%. Distributions are scheduled quarterly.

The 30-day SEC Yield was 0.69% as of 30 September 2026. This standardised income measure reflects the fund’s recent income after expenses; it is separate from changes in the market value of its shares.

The prospectus notes that brokerage commissions and other intermediary charges may apply separately. Fund shares trade at market prices, which can differ from NAV, so the stated NAV does not establish the price of every exchange transaction.

Key Insights

Regulation, product development, technological change and competition can affect medical equipment businesses. The portfolio’s industry focus makes those developments relevant across its holdings without removing issuer-specific risk.